Silo Pharma (SILO) Competitors $0.61 -0.02 (-3.20%) Closing price 07/3/2025 03:56 PM EasternExtended Trading$0.62 +0.01 (+0.99%) As of 07/3/2025 04:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, MGOL, EVKG, ONON, LULU, AS, BIRK, LEVI, GIL, and BRPShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), MGO Global (MGOL), Ever-Glory International Group (EVKG), ON (ONON), lululemon athletica (LULU), Amer Sports (AS), Birkenstock (BIRK), Levi Strauss & Co. (LEVI), Gildan Activewear (GIL), and The Baldwin Insurance Group (BRP). These companies are all part of the "apparel" industry. Silo Pharma vs. Its Competitors Perfect Moment MGO Global Ever-Glory International Group ON lululemon athletica Amer Sports Birkenstock Levi Strauss & Co. Gildan Activewear The Baldwin Insurance Group Perfect Moment (NASDAQ:PMNT) and Silo Pharma (NASDAQ:SILO) are both small-cap apparel companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends. Does the media refer more to PMNT or SILO? In the previous week, Perfect Moment had 5 more articles in the media than Silo Pharma. MarketBeat recorded 6 mentions for Perfect Moment and 1 mentions for Silo Pharma. Perfect Moment's average media sentiment score of 0.75 beat Silo Pharma's score of 0.00 indicating that Perfect Moment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Perfect Moment 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Silo Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is PMNT or SILO more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -6,420.83%. Silo Pharma's return on equity of -84.88% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Perfect Moment-67.38% -513.83% -119.38% Silo Pharma -6,420.83%-84.88%-61.81% Which has preferable valuation and earnings, PMNT or SILO? Silo Pharma has lower revenue, but higher earnings than Perfect Moment. Silo Pharma is trading at a lower price-to-earnings ratio than Perfect Moment, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPerfect Moment$21.50M0.27-$8.72M-$0.99-0.30Silo Pharma$70K38.98-$4.39M-$1.17-0.52 Do analysts prefer PMNT or SILO? Perfect Moment currently has a consensus target price of $6.00, suggesting a potential upside of 1,920.20%. Given Perfect Moment's stronger consensus rating and higher possible upside, equities research analysts clearly believe Perfect Moment is more favorable than Silo Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Silo Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, PMNT or SILO? Perfect Moment has a beta of -3.74, indicating that its stock price is 474% less volatile than the S&P 500. Comparatively, Silo Pharma has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500. Do institutionals & insiders hold more shares of PMNT or SILO? 23.0% of Perfect Moment shares are owned by institutional investors. Comparatively, 5.6% of Silo Pharma shares are owned by institutional investors. 4.4% of Silo Pharma shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryPerfect Moment beats Silo Pharma on 10 of the 16 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SILO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.76M$2.91B$5.53B$9.05BDividend YieldN/A2.44%5.24%4.03%P/E Ratio-0.5221.5627.5220.22Price / Sales38.98281.76421.02118.64Price / CashN/A42.7336.8958.07Price / Book0.547.518.045.67Net Income-$4.39M-$55.05M$3.18B$249.13M7 Day Performance-4.99%4.61%2.90%3.28%1 Month Performance-4.84%4.72%3.70%5.56%1 Year Performance-36.73%5.92%36.15%21.12% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.3344 of 5 stars$0.61-3.2%N/A-36.2%$2.76M$70K-0.522PMNTPerfect Moment3.2635 of 5 stars$0.23-14.3%$6.00+2,491.8%-82.1%$3.84M$21.31M-0.1831Upcoming EarningsInsider TradeGap UpHigh Trading VolumeMGOLMGO GlobalN/A$0.31-33.8%N/A-94.0%$894K$5.20M-0.077Gap DownHigh Trading VolumeEVKGEver-Glory International GroupN/A$0.00+100.0%N/AN/A$21KN/A0.004,300ONONON3.3402 of 5 stars$52.28+0.4%$63.85+22.1%+48.0%$32.92B$2.63B74.693,254Options VolumeLULUlululemon athletica4.8224 of 5 stars$245.12+3.2%$338.73+38.2%-17.5%$29.38B$10.59B16.6139,000Trending NewsInsider TradeOptions VolumeASAmer Sports1.9437 of 5 stars$37.68-2.8%$37.81+0.3%+210.2%$20.87B$5.18B101.8413,400BIRKBirkenstock3.3513 of 5 stars$49.00-0.4%$69.27+41.4%-12.7%$9.20B$1.96B34.517,400LEVILevi Strauss & Co.3.7675 of 5 stars$18.87+2.1%$20.55+8.9%-0.2%$7.47B$6.40B21.2018,700News CoverageUpcoming EarningsAnalyst ForecastGILGildan Activewear4.6217 of 5 stars$49.48+0.5%$57.91+17.0%+31.9%$7.45B$3.27B19.1050,000BRPThe Baldwin Insurance GroupN/A$42.81+0.3%N/A+12.9%$5.03B$1.27B-46.539,200 Related Companies and Tools Related Companies Perfect Moment Competitors MGO Global Competitors Ever-Glory International Group Competitors ON Competitors lululemon athletica Competitors Amer Sports Competitors Birkenstock Competitors Levi Strauss & Co. Competitors Gildan Activewear Competitors The Baldwin Insurance Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
